Quick Answer
InspireMD, Inc. reported Earnings Per Share Diluted of $0.76 (loss) per share for the year ending 2025.
- InspireMD, Inc. showed an increase of +0.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from InspireMD, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2022: $0.59 (loss) per share | Q3 2022: $0.58 (loss) per share | Q1 2023: $0.53 (loss) per share | Q2 2023: $0.24 (loss) per share | Q3 2023: $0.15 (loss) per share | Q1 2024: $0.21 (loss) per share | Q2 2024: $0.22 (loss) per share | Q3 2024: $0.16 (loss) per share | Q1 2025: $0.22 (loss) per share | Q2 2025: $0.26 (loss) per share | Q3 2025: $0.17 (loss) per share.
- Over the full 4 years of available data (2022 to 2025), InspireMD, Inc.'s Earnings Per Share Diluted has grown by 67.7%.
- Historical annual values: Fiscal year 2025: $0.76 (loss) per share | Fiscal year 2024: $0.76 (loss) per share | Fiscal year 2023: $0.82 (loss) per share | Fiscal year 2022: $2.35 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: